MOTS-C: Mitochondrial Peptide Research

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-C) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically within the 12S rRNA gene. Discovered in 2015 by a team led by Changhan David Lee at the University of Southern California, MOTS-C represents a new class of mitochondria-derived peptides (MDPs) with systemic signaling functions. Its discovery challenged the classical view of mitochondria as purely metabolic organelles and opened a new line of research into mitochondrial-nuclear communication.

AMPK Pathway Activation

MOTS-C's primary characterized mechanism involves activation of AMPK (AMP-activated protein kinase), the central cellular energy sensor. In the proposed model, MOTS-C translocates from mitochondria to the nucleus under conditions of metabolic stress, where it interacts with AMPK-related signaling cascades to regulate gene expression associated with energy homeostasis. AMPK activation has broad downstream effects: suppression of anabolic pathways (mTORC1 signaling, lipogenesis, gluconeogenesis) and promotion of catabolic processes (fatty acid oxidation, autophagy, glucose uptake via GLUT4 translocation).

Insulin Sensitivity and Metabolic Research

Initial studies characterizing MOTS-C focused on its effects in insulin resistance models. In murine high-fat diet models, MOTS-C administration was associated with improvements in insulin-stimulated glucose uptake, reduction in fasting glucose, and modulation of adipose tissue inflammation markers. Subsequent work has examined its role in skeletal muscle metabolism, where AMPK-dependent GLUT4 upregulation is a key research endpoint. Aging models have also been of interest, as MOTS-C plasma levels appear to decline with age in both rodent and human observational studies.

Mitochondrial-Nuclear Communication

The broader significance of MOTS-C research extends beyond its acute metabolic effects. As a retrograde mitochondria-to-nucleus signaling peptide, MOTS-C is being studied as a model for understanding how mitochondrial functional status communicates with nuclear gene expression programs. This places it at the intersection of aging biology, metabolic disease research, and cellular stress response. Research using MOTS-C as a probe has contributed to better characterization of the mitochondrial peptidome more broadly.

Protocol and Purity Notes

MOTS-C is a small, 16-residue peptide with a molecular weight of approximately 2174 Da. It is soluble in aqueous buffers and typically reconstituted in PBS or bacteriostatic water for in vitro use. Sequence fidelity is critical — single residue substitutions at key positions can abrogate AMPK activation. Researchers should verify identity by MS and confirm HPLC purity ≥98% before use. Stored lyophilized at −20°C, MOTS-C is stable for 24+ months under appropriate conditions.

PeptoBuy supplies research-grade MOTS-C (10 mg lyophilized per vial) for qualified researchers and laboratories. Each batch is independently third-party tested with COA available on request. For in vitro research use only — not for human or animal consumption.